CD274 and lung carcinoma: Finally, TPP‐LND@Lip synergistically increased DNA damage and sensitized radiotherapy via PD‐L1 downregulation and hypoxia reversion by inhibiting mitochondrial OXPHOS, which then significantly inhibited the growth of lung cancer.